Cardinal Health Inc. (NYSE:CAH) has been given a $88.00 target price by Barclays PLC in a research report issued to clients and investors on Monday. The brokerage currently has a a “buy” rating on the stock. Barclays PLC’s target price would indicate a potential upside of 21.63% from the stock’s current price.

Several other equities research analysts have also recently issued reports on CAH. Citigroup Inc. boosted their price target on Cardinal Health from $87.00 to $93.00 and gave the company a “neutral” rating in a research note on Wednesday, August 3rd. Leerink Swann reiterated a “buy” rating on shares of Cardinal Health in a research note on Wednesday, August 3rd. Zacks Investment Research upgraded Cardinal Health from a “sell” rating to a “hold” rating in a research note on Monday. Goldman Sachs Group Inc. cut Cardinal Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $90.00 to $83.00 in a research note on Friday, September 16th. Finally, Deutsche Bank AG boosted their price target on Cardinal Health from $83.00 to $89.00 and gave the company a “hold” rating in a research note on Thursday, August 4th. Ten research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $91.62.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Cardinal Health (NYSE:CAH) opened at 72.35 on Monday. Cardinal Health has a 12 month low of $62.70 and a 12 month high of $91.23. The stock has a market capitalization of $23.16 billion, a price-to-earnings ratio of 17.51 and a beta of 0.73. The stock’s 50 day moving average is $73.51 and its 200-day moving average is $78.18.

Cardinal Health (NYSE:CAH) last posted its earnings results on Monday, October 31st. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.21 by $0.03. Cardinal Health had a return on equity of 25.20% and a net margin of 1.08%. The company had revenue of $32 billion for the quarter, compared to the consensus estimate of $31.12 billion. During the same quarter in the prior year, the business earned $1.38 earnings per share. The firm’s revenue for the quarter was up 14.2% on a year-over-year basis. On average, equities research analysts expect that Cardinal Health will post $5.47 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Sunday, January 15th. Investors of record on Tuesday, January 3rd will be issued a $0.4489 dividend. The ex-dividend date of this dividend is Thursday, December 29th. This represents a $1.80 dividend on an annualized basis and a yield of 2.48%. Cardinal Health’s payout ratio is 43.58%.

In other Cardinal Health news, Chairman George S. Barrett sold 217,995 shares of the stock in a transaction dated Thursday, November 10th. The stock was sold at an average price of $71.29, for a total transaction of $15,540,863.55. Following the completion of the sale, the chairman now directly owns 682,226 shares in the company, valued at approximately $48,635,891.54. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Stuart G. Laws sold 9,703 shares of the stock in a transaction dated Thursday, August 18th. The stock was sold at an average price of $82.45, for a total value of $800,012.35. Following the sale, the senior vice president now owns 2,718 shares of the company’s stock, valued at $224,099.10. The disclosure for this sale can be found here. 0.94% of the stock is owned by corporate insiders.

A number of hedge funds have recently modified their holdings of CAH. Integrated Investment Consultants LLC increased its stake in shares of Cardinal Health by 15.4% in the second quarter. Integrated Investment Consultants LLC now owns 1,459 shares of the company’s stock worth $114,000 after buying an additional 195 shares during the last quarter. JFS Wealth Advisors LLC increased its stake in shares of Cardinal Health by 8,281.0% in the second quarter. JFS Wealth Advisors LLC now owns 1,760 shares of the company’s stock worth $137,000 after buying an additional 1,739 shares during the last quarter. Quadrant Capital Group LLC increased its stake in shares of Cardinal Health by 2.4% in the third quarter. Quadrant Capital Group LLC now owns 1,906 shares of the company’s stock worth $142,000 after buying an additional 44 shares during the last quarter. Advisory Services Network LLC increased its stake in shares of Cardinal Health by 398.2% in the second quarter. Advisory Services Network LLC now owns 1,948 shares of the company’s stock worth $152,000 after buying an additional 1,557 shares during the last quarter. Finally, Acrospire Investment Management LLC increased its stake in shares of Cardinal Health by 150.0% in the third quarter. Acrospire Investment Management LLC now owns 2,000 shares of the company’s stock worth $155,000 after buying an additional 1,200 shares during the last quarter. Hedge funds and other institutional investors own 88.19% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

5 Day Chart for NYSE:CAH

Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.